You are viewing a single comment's thread.

view the rest of the comments →

MercurysBall2 ago

Transgene "designs and develops therapeutic vaccines and immunotherapy products to treat cancers and infectious diseases" and is owned at 55% by the holding https://www.institut-merieux.com/en/public-health/transgene/

Along with this research, Transgene’s strategy is to identify prognostic and predictive “biomarkers” to anticipate a patient’s response to therapy in order to improve product efficacy and provide more personalized medicine.

About transgenes https://en.wikipedia.org/wiki/Transgene

The idea of shaping an organism to fit a specific need isn't a new science

Uh huh...

Ethical controversy

Transgene use in humans is currently fraught with issues. Transformation of genes into human cells has not been perfected yet. The most famous example of this involved certain patients developing T-cell leukemia after being treated for X-linked severe combined immunodeficiency (X-SCID).[28] This was attributed to the close proximity of the inserted gene to the LMO2 promoter, which controls the transcription of the LMO2 proto-oncogene.[29] In common with most forms of genetic engineering, the use of transgenes for purposes other than to correct life-threatening genetic abnormalities is a major bioethical issue